| Released | Contributor | Author | Title | Pages | Price |
| 29-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Medifast has a current Overall Rating of A (Highest Rating). | 7 |
$25 |
| 27-Nov-2009 | Validea |
N/A
| Validea Guru Analysis Report for MED. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others. | 0 |
$18 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: MEDIFAST -- MED | 1 |
$4 |
| 23-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Food & Beverages Intelligence Monitor: overall outlook NEUTRAL - 25 new Leaders; 14 new Laggards. | 54 |
$20 |
| 23-Nov-2009 | Reuters Investment Profile |
N/A
| Medifast Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Retail Industry Market Research and Competitive Analysis 2009 | 675 |
$299 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Retail Industry Trends, Statistics & Analysis 2009 (Summary) | 54 |
$199 |
| 23-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for MED | 13 |
$25 |
| 23-Nov-2009 | Market Edge |
N/A
| Market Edge Equity Research Report | 4 |
$10 |
| 22-Nov-2009 | Wright Reports |
N/A
| Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) | 101 |
$169 |
1.48% Nasdaq 
Research Reports
